Shaily Engineering Plastics Limited has informed the Exchange regarding Outcome of Board Meeting held on May 19, 2026.
SHAILY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Shaily Engineering Plastics reported strong FY26 results with standalone revenue growing 21.5% to ₹921.2 crore and net profit more than doubling to ₹161.3 crore compared to FY25. Consolidated revenue rose 25.9% to ₹990.7 crore with net profit of ₹169.9 crore, up 82.5% year-on-year. The Board recommended a dividend of Rs. 3 per share (150%). The company also approved appointment of new internal and cost auditors, and appointed Mr. Chi Hung Kam as COO-Healthcare. Most significantly, an enabling resolution was passed for raising up to ₹500 crore to fund expansion into healthcare (drug delivery devices), consumer electronics, and semiconductor tray manufacturing through a new supply agreement with a Korean firm.
Strong financial performance with over 20% revenue growth and 80%+ profit growth demonstrates solid execution. The ₹500 crore fund raise approval signals aggressive expansion plans into new high-growth segments like semiconductors and healthcare, which could significantly re-rate the stock if executed well.